Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram

• Status: Completed
• Trial end date: 2022-10-30
• Target enrollment: 0
• Participant gender: Male

Summary

Worldwide infertility affects about 15 % of reproductive-age couples. In many cases, infertility can't be treated, new treatment options with promising value were involved in the recent clinical trials.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Al-Mustansiriyah University
• Collaborator: Al-Nahrain University
• Treatments: Coenzyme Q10; Letrozole; Ubiquinone

Criteria

Inclusion Criteria:

1. Adult male patients.

2. Aged 18 - 60 years.

3. Confirmed diagnosis with idiopathic Oligo-Astheno-Teratozoospermia (iOAT) syndrome.

Exclusion Criteria:

1. Patients who have been found to have additional infertility causes, such as varicocele or Obstruction of the ejaculatory duct.

2. Those who have had surgery for male factor infertility.

3. Patients with infections such as STD.

4. Patient with renal or liver disease

5. Incomplete patient data